These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21762646)

  • 1. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
    Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M
    Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T; Igarashi T; Shimizu A; Itoh Y
    J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
    Ogawa H; Kameda H; Amano K; Takeuchi T
    Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
    Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
    Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis.
    Sawamura M; Sawa N; Ikuma D; Oba Y; Yamanouchi M; Sekine A; Mizuno H; Hasegawa E; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Ubara Y
    Intern Med; 2023 Apr; 62(7):1037-1041. PubMed ID: 36070938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.
    Dostál C; Tesar V; Rychlík I; Zabka J; Vencovský J; Bartûnková J; Stejskalová A; Tegzova D
    Lupus; 1998; 7(1):29-36. PubMed ID: 9493146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis.
    Daleboudt GM; Broadbent E; Berger SP; Kaptein AA
    Lupus; 2011 Mar; 20(3):290-8. PubMed ID: 21362752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.
    Hallegua D; Wallace DJ; Metzger AL; Rinaldi RZ; Klinenberg JR
    Lupus; 2000; 9(4):241-51. PubMed ID: 10866094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease.
    Dong G; Panaro F; Bogetti D; Sammartino C; Rondelli D; Sankary H; Testa G; Benedetti E
    Clin Transplant; 2005 Feb; 19(1):56-60. PubMed ID: 15659135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis.
    Aragon E; Chan YH; Ng KH; Lau YW; Tan PH; Yap HK
    Lupus; 2010 Jul; 19(8):965-73. PubMed ID: 20581019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
    Koo HS; Kim S; Chin HJ
    Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Kronbichler A; Neumann I; Mayer G
    Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
    Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
    Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.
    Závada J; Sinikka Pesicková S; Rysavá R; Horák P; Hrncír Z; Lukác J; Rovensky J; Vítová J; Havrda M; Rychlík I; Böhmova J; Vlasáková V; Slatinská J; Zadrazil J; Olejárová M; Tegzova D; Tesar V
    Lupus; 2014; 23(1):69-74. PubMed ID: 24213308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression.
    Castro M; Ugolini-Lopes M; Borba EF; Bonfá E; Seguro LPC
    Lupus; 2018 Dec; 27(14):2215-2219. PubMed ID: 30394834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
    Moroni G; Doria A; Ponticelli C
    Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients.
    Sazliyana S; Mohd Shahrir MS; Kong CT; Tan HJ; Hamidon BB; Azmi MT
    Lupus; 2011 Oct; 20(12):1260-6. PubMed ID: 21844115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.